CoChat
Sign Up
Cited by 34

Hsa-miR-574-5p negatively regulates MACC-1 expression to suppress colorectal cancer liver metastasis

Cui, Zhe, Tang, Jian, Chen, Jinxian, Wang, Zheng·2014·Cancer Cell International
DOI 10.1186/1475-2867-14-47PMC PMC4059478
Open this paper in CoChat — free account

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/1475-2867-14-47

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • miR-574* (5p) is oncogenic in colorectal cancer, NSCLC, and PTC, while miR-574 (3p) is tumor suppressive in breast cancer and leukemia.

    “miR‐574* (5p) is oncogenic in colorectal cancer, NSCLC, and PTC (Cui, Tang, Chen, & Wang, 2014; Ji et al., 2012; Ma et al., 2016; X. Wang, Lu, Geng, Yang, & Shi, 2017; Zhou et al., 2015; Zhou et al., 2016), while miR‐574 (3p) is tumor suppressive in breast cancer and leukemia (Chiyomaru et al., 2013; Ujihira et al., 2015; Xu et al., 2020; Yao, Wu, Lindner, & Fox, 2017).”

    From microRNA strand selection: Unwinding the rules (2021) · cites this paper as Cui, Tang, Chen, & Wang, 2014

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 34

  1. Nordlinger B Sorbye H Glimelius B Poston GJ Schlag PM Rougier P Bechstein WO Primrose JN Walpole ET Finch-Jones M Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial Lancet 2008 371 9617 1007 1016 10.1016/S0140-6736(08)60455-9 18358928 PMC2277487 · DOI
  2. Petri A Hohn J Balogh A Kovách K Andrási L Lázár G Surgical treatment of liver metastasis in colorectal cancer with simultaneous liver resection Magy Onkol 2010 54 2 125 128 10.1556/MOnkol.54.2010.2.6 20576588 · DOI
  3. Huh JW Cho CK Kim HR Kim YJ Impact of resection for primary colorectal cancer on outcomes in patients with synchronous colorectal liver metastases J Gastrointest Surg 2010 14 8 1258 1264 10.1007/s11605-010-1250-7 20544397 · DOI
  4. Kornprat P DeMatteo RP Blumgart LH Jarnagin WR Effect on outcome of recurrence patterns after hepatectomy for colorectal metastases Ann Surg Oncol 2011 18 4 1096 1103 10.1245/s10434-010-1409-1 21042942 · DOI
  5. Fidler IJ The pathogenesis of cancer metastasis: the‘seed and soil’hypothesis revisited Nat Rev Cancer 2003 3 6 453 458 10.1038/nrc1098 12778135 · DOI · Paper page
  6. Mani SA Guo W Liao M-J Eaton EN Ayyanan A Zhou AY Brooks M Reinhard F Zhang CC Shipitsin M The epithelial-mesenchymal transition generates cells with properties of stem cells Cell 2008 133 4 704 715 10.1016/j.cell.2008.03.027 18485877 PMC2728032 · DOI
  7. Kitayama J Nagawa H Tsuno N Osada T Hatano K Sunami E Saito H Muto T Laminin mediates tethering and spreading of colon cancer cells in physiological shear flow Br J Cancer 1999 80 12 1927 10.1038/sj.bjc.6690622 10471041 PMC2363138 · DOI
  8. Arap W Pasqualini R Ruoslahti E Cancer treatment by targeted drug delivery to tumor vasculature in a mouse model Science 1998 279 5349 377 380 10.1126/science.279.5349.377 9430587 · DOI
  9. Stein U Walther W Arlt F Schwabe H Smith J Fichtner I Birchmeier W Schlag PM MACC1, a newly identified key regulator of HGF-MET signaling, predicts colon cancer metastasis Nat Med 2008 15 1 59 67 19098908
  10. Yang J Mani SA Weinberg RA Exploring a new twist on tumor metastasis Cancer Res 2006 66 9 4549 4552 10.1158/0008-5472.CAN-05-3850 16651402 · DOI
  11. Paschos KA Canovas D Bird NC The role of cell adhesion molecules in the progression of colorectal cancer and the development of liver metastasis Cell Signal 2009 21 5 665 674 10.1016/j.cellsig.2009.01.006 19167485 · DOI
  12. Li C Wu JJ Hynes M Dosch J Sarkar B Welling TH Pasca di Magliano M Simeone DM c-Met is a marker of pancreatic cancer stem cells and therapeutic target Gastroenterology 2011 141 6 2218 2227 e2215 10.1053/j.gastro.2011.08.009 21864475 · DOI
  13. Li Y Li A Glas M Lal B Ying M Sang Y Xia S Trageser D Guerrero-Cázares H Eberhart CG c-Met signaling induces a reprogramming network and supports the glioblastoma stem-like phenotype Proc Natl Acad Sci 2011 108 24 9951 9956 10.1073/pnas.1016912108 21628563 PMC3116406 · DOI
  14. Zhang Y Wang Z Chen M Peng L Wang X Ma Q Ma F Jiang B MicroRNA-143 targets MACC1 to inhibit cell invasion and migration in colorectal cancer Mol Cancer 2012 11 1 23 10.1186/1476-4598-11-23 22533346 PMC3351020 · DOI
  15. Migliore C Martin V Leoni VP Restivo A Atzori L Petrelli A Isella C Zorcolo L Sarotto I Casula G MiR-1 downregulation cooperates with MACC1 in promoting MET overexpression in human colon cancer Clin Cancer Res 2012 18 3 737 747 10.1158/1078-0432.CCR-11-1699 22179665 · DOI
  16. Cho W MicroRNAs: potential biomarkers for cancer diagnosis, prognosis and targets for therapy Int J Biochem Cell Biol 2010 42 8 1273 1281 10.1016/j.biocel.2009.12.014 20026422 · DOI
  17. Pizzini S Bisognin A Mandruzzato S Biasiolo M Facciolli A Perilli L Rossi E Esposito G Rugge M Pilati P Impact of microRNAs on regulatory networks and pathways in human colorectal carcinogenesis and development of metastasis BMC Genomics 2013 14 1 589 10.1186/1471-2164-14-589 23987127 PMC3766699 · DOI
  18. Michael MZ O’Connor SM van Holst Pellekaan NG Young GP James RJ Reduced Accumulation of Specific MicroRNAs in Colorectal Neoplasia11Note: Susan M. O’Connor and Nicholas G. van Holst Pellekaan contributed equally to this work Mol Cancer Res 2003 1 12 882 891 14573789
  19. Cho W Chow AS Au JS Restoration of tumour suppressor hsa-miR-145 inhibits cancer cell growth in lung adenocarcinoma patients with epidermal growth factor receptor mutation Eur J Cancer 2009 45 12 2197 2206 10.1016/j.ejca.2009.04.039 19493678 · DOI
  20. Schetter AJ Nguyen GH Bowman ED Mathé EA Yuen ST Hawkes JE Croce CM Leung SY Harris CC Association of inflammation-related and microRNA gene expression with cancer-specific mortality of colon adenocarcinoma Clin Cancer Res 2009 15 18 5878 5887 10.1158/1078-0432.CCR-09-0627 19737943 PMC2745503 · DOI
  21. Kalabus JL Cheng Q Blanco JG MicroRNAs differentially regulate carbonyl reductase 1 (CBR1) gene expression dependent on the allele status of the common polymorphic variant rs9024 PLoS One 2012 7 11 e48622 10.1371/journal.pone.0048622 23133646 PMC3486798 · DOI
  22. Ji S Ye G Zhang J Wang L Wang T Wang Z Zhang T Wang G Guo Z Luo Y miR-574-5p negatively regulates Qki6/7 to impact β-catenin/Wnt signalling and the development of colorectal cancer Gut 2013 62 5 716 726 10.1136/gutjnl-2011-301083 22490519 PMC3618686 · DOI
  23. Karlsson H Fryknäs M Larsson R Nygren P Loss of cancer drug activity in colon cancer HCT-116 cells during spheroid formation in a new 3-D spheroid cell culture system Exp Cell Res 2012 318 13 1577 1585 10.1016/j.yexcr.2012.03.026 22487097 · DOI · Paper page
  24. Ma L Teruya-Feldstein J Weinberg RA Tumour invasion and metastasis initiated by microRNA-10b in breast cancer Nature 2007 449 7163 682 688 10.1038/nature06174 17898713 · DOI · Paper page
  25. Tavazoie SF Alarcón C Oskarsson T Padua D Wang Q Bos PD Gerald WL Massagué J Endogenous human microRNAs that suppress breast cancer metastasis Nature 2008 451 7175 147 152 10.1038/nature06487 18185580 PMC2782491 · DOI
  26. Gibbons DL Lin W Creighton CJ Rizvi ZH Gregory PA Goodall GJ Thilaganathan N Du L Zhang Y Pertsemlidis A Contextual extracellular cues promote tumor cell EMT and metastasis by regulating miR-200 family expression Genes Dev 2009 23 18 2140 2151 10.1101/gad.1820209 19759262 PMC2751985 · DOI
  27. Saydam O Shen Y Würdinger T Senol O Boke E James MF Tannous BA Stemmer-Rachamimov AO Yi M Stephens RM Downregulated microRNA-200a in meningiomas promotes tumor growth by reducing E-cadherin and activating the Wnt/β-catenin signaling pathway Mol Cell Biol 2009 29 21 5923 5940 10.1128/MCB.00332-09 19703993 PMC2772747 · DOI
  28. Sachdeva M Mo Y-Y MicroRNA-145 suppresses cell invasion and metastasis by directly targeting mucin 1 Cancer Res 2010 70 1 378 387 10.1158/0008-5472.CAN-09-2021 19996288 PMC2805032 · DOI
  29. Stein U Dahlmann M Walther W MACC1—more than metastasis? Facts and predictions about a novel gene J Mol Med 2010 88 1 11 18 10.1007/s00109-009-0537-1 19787327 · DOI
  30. Stein U Smith J Walther W Arlt F MACC1 controls Met: what a difference an Sp1 site makes Cell Cycle 2009 8 15 2467 2469 10.4161/cc.8.15.9018 19556890 · DOI
  31. Arlt F Stein U Colon cancer metastasis: MACC1 and Met as metastatic pacemakers Int J Biochem Cell Biol 2009 41 12 2356 2359 10.1016/j.biocel.2009.08.001 19666136 · DOI
  32. Birchmeier C Birchmeier W Gherardi E Woude GFV Met, metastasis, motility and more Nat Rev Mol Cell Biol 2003 4 12 915 925 10.1038/nrm1261 14685170 · DOI
  33. Zeng Z-S Weiser MR Kuntz E Chen C-T Khan SA Forslund A Nash GM Gimbel M Yamaguchi Y Culliford AT IV c-Met gene amplification is associated with advanced stage colorectal cancer and liver metastases Cancer Lett 2008 265 2 258 269 10.1016/j.canlet.2008.02.049 18395971 PMC4367187 · DOI
  34. Larsen CA Dashwood RH Suppression of Met activation in human colon cancer cells treated with (-)-epigallocatechin-3-gallate: Minor role of hydrogen peroxide Biochem Biophys Res Commun 2009 389 3 527 530 10.1016/j.bbrc.2009.09.019 19744467 PMC2761952 · DOI

Cited by

Sorted by citations

Authors
Cui, Z., Tang, J., Chen, J., & Wang, Z.
Venue
Cancer Cell International
Publisher
Springer Science and Business Media LLC
Published
2014-06-07
Volume
14
Issue
1
ISSN
1475-2867
DOI
10.1186/1475-2867-14-47
PMC
PMC4059478
Cited by
34
References
1
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review